Gang Fang, Pharm.D., Ph.D.
Gang Fang, Pharm.D., Ph.D.

Gang Fang, Pharm.D., Ph.D., has been promoted to the rank of associate professor with tenure in the Division of Pharmaceutical Outcomes and Policy at the UNC Eshelman School of Pharmacy.

Fang’s research centers on evaluating treatment utilization and outcomes in populations and pharmacoepidemiology, especially in cardiovascular disease. Fang’s research primarily focuses on estimating real-world comparative treatment effectiveness and safety, identifying optimal treatment strategies, assessing treatment variation in large populations, assessing quality of care related to the treatment variation, medication adherence, and treatment disparities particularly in the elderly and minorities, and developing innovative analytical methods using observational data from large health-care-utilization databases.

Since 2009, Fang has been a key co-investigator or principal investigator for studies totaling more than $7.4 million — with close to $2.5 million as principle investigator, including R01 and R21 grants — funded by the American Heart Association, the National Institutes of Health, the Agency for Healthcare Research and Quality and the Patient-Centered Outcomes Research Institute. Fang’s studies have been published in clinical and academic journals, such as Circulation, Journal of American College of Cardiology, American Journal of Epidemiology, and Medicare Care. He has been an invited reviewer for the Journal of the American Medical Association, Circulation and the Annals of Internal Medicine, among others.

Fang joined the School in 2011 as an assistant professor. He is a research fellow of the UNC Cecil G. Sheps Center for Health Services Research and directed the GSK Pharmaceutical Outcomes Research Postdoctoral Fellowship Program in DPOP from 2014 to 2017. Prior to joining the faculty at UNC-Chapel Hill, he served as a research scientist at the University of Iowa. During his time at the School, Fang has served as the dissertation adviser for three Ph.D. students, a dissertation committee member for five Ph.D. students and research mentor for four postdoctoral fellows, a visiting research scholar from Finland and six Pharm.D. students, as well as research adviser for several high school and undergraduate students.

Fang received his Ph.D. in epidemiology and a master of science in pharmaceutical socioeconomics from the University of Iowa. He earned his Pharm.D. from the University of Maryland.


Comments are closed.